Astaxanthin is a valuable ketocarotenoid with various pharmaceutical and nutraceutical applications. Green microalgae harbor natural capacities for pigment accumulation due to their 2--methyl-d-erythritol 4-phosphate (MEP) pathway. Recently, a redesigned ß-carotene ketolase (BKT) was found to enable ketocarotenoid accumulation in the model microalga , and transformants exhibited reduced photoinhibition under high-light. Here, a systematic screening by synthetic transgene design of carotenoid pathway enzymes and overexpression from the nuclear genome identified phytoene synthase (PSY/crtB) as a bottleneck for carotenoid accumulation in . Increased ß-carotene hydroxylase (CHYB) activity was found to be essential for engineered astaxanthin accumulation. A combined BKT, crtB, and CHYB expression strategy resulted in a volumetric astaxanthin production of 9.5 ± 0.3 mg L (4.5 ± 0.1 mg g CDW) in mixotrophic and 23.5 mg L (1.09 mg L h) in high cell density conditions, a 4-fold increase compared to previous reports in . This work presents a systematic investigation of bottlenecks in astaxanthin accumulation in and the phototrophic green cell factory design for competitive use in industrial biotechnology.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acssynbio.2c00616 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!